Citations (58)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Dong-Ming Zhou, Yan-Xia Xu, Li-Ying Zhang, Yu Sun, Zi-Yan Wang, Yu-Qing Yuan & Jin-Xiang Fu. (2017) The role of follicular T helper cells in patients with malignant lymphoid disease. Hematology 22:7, pages 412-418.
Read now
Read now
Qiyi Zhao, Zhan-Lian Huang, Min He, Zhiliang Gao & Dong-Ming Kuang. (2016) BTLA identifies dysfunctional PD-1-expressing CD4+ T cells in human hepatocellular carcinoma. OncoImmunology 5:12.
Read now
Read now
Fernando Aranda, Erika Vacchelli, Florine Obrist, Alexander Eggermont, Jérôme Galon, Wolf Hervé Fridman, Isabelle Cremer, Eric Tartour, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2014) Trial Watch. OncoImmunology 3:5.
Read now
Read now
Erika Vacchelli, Alexander Eggermont, Wolf Hervé Fridman, Jérôme Galon, Eric Tartour, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2013) Trial Watch. OncoImmunology 2:5.
Read now
Read now
Lorenzo Galluzzi & Enrico Lugli. (2013) Rejuvenated T cells attack old tumors. OncoImmunology 2:2.
Read now
Read now
Erika Vacchelli, Alexander Eggermont, Jérôme Galon, Catherine Sautès-Fridman, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2013) Trial watch. OncoImmunology 2:1.
Read now
Read now
Articles from other publishers (52)
Krisztian Homicsko, Panagiota Zygoura, Maxim Norkin, Stephanie Tissot, Nicholas Shakarishvili, Sanjay Popat, Alessandra Curioni-Fontecedro, Mary O'Brien, Anthony Pope, Riyaz Shah, Patricia Fisher, James Spicer, Amy Roy, David Gilligan, Sylvie Rusakiewicz, Ekaterina Fortis, Nesa Marti, Roswitha Kammler, Stephen P Finn, Georges Coukos, Urania Dafni, Solange Peters & Rolf A Stahel. (2023) PD-1-expressing macrophages and CD8 T cells are independent predictors of clinical benefit from PD-1 inhibition in advanced mesothelioma. Journal for ImmunoTherapy of Cancer 11:10, pages e007585.
Crossref
Crossref
Ensiye Torki, Arezou Gharezade, Mehrnoosh Doroudchi, Shima Sheikhi, Davood Mansury, Mark J. M. Sullman & Hamed Fouladseresht. (2023) The kinetics of inhibitory immune checkpoints during and post-COVID-19: the knowns and unknowns. Clinical and Experimental Medicine 23:7, pages 3299-3319.
Crossref
Crossref
Heqi Gao, Xinwen Qi, Jingtian Zhang, Nan Wang, Jingrui Xin, Di Jiao, Kaining Liu, Ji Qi, Yong Guan & Dan Ding. (2023) Smart One‐for‐All Agent with Adaptive Functions for Improving Photoacoustic /Fluorescence Imaging‐Guided Photodynamic Immunotherapy. Small Methods 7:5.
Crossref
Crossref
Tetsuhiro Kasamatsu, Maaya Awata-Shiraiwa, Rei Ishihara, Yuki Murakami, Yuta Masuda, Nanami Gotoh, Tsukasa Oda, Akihiko Yokohama, Ikuko Matsumura, Hiroshi Handa, Norifumi Tsukamoto, Hirokazu Murakami & Takayuki Saitoh. (2023) Sub-lethal doses of chemotherapeutic agents induce senescence in T cells and upregulation of PD-1 expression. Clinical and Experimental Medicine.
Crossref
Crossref
Sacha Zinn, Rodrigo Vazquez-Lombardi, Carsten Zimmermann, Puja Sapra, Lutz Jermutus & Daniel Christ. (2023) Advances in antibody-based therapy in oncology. Nature Cancer 4:2, pages 165-180.
Crossref
Crossref
Emily Cassar, Apriliana E. R. Kartikasari & Magdalena Plebanski. (2022) Regulatory T Cells in Ovarian Carcinogenesis and Future Therapeutic Opportunities. Cancers 14:22, pages 5488.
Crossref
Crossref
Domenico Mallardo, Diana Giannarelli, Maria Grazia Vitale, Domenico Galati, Giusy Trillò, Assunta Esposito, Maria Antonietta Isgrò, Grazia D'Angelo, Lucia Festino, Vito Vanella, Claudia Trojaniello, Andrew White, Teresa De Cristofaro, Michael Bailey, Sandro Pignata, Corrado Caracò, Antonella Petrillo, Paolo Muto, Piera Maiolino, Alfredo Budillon, Sarah Warren, Ernesta Cavalcanti & Paolo Antonio Ascierto. (2022) Nivolumab serum concentration in metastatic melanoma patients could be related to outcome and enhanced immune activity: a gene profiling retrospective analysis. Journal for ImmunoTherapy of Cancer 10:11, pages e005132.
Crossref
Crossref
Alexander F. Haddad, Jacob S. Young, Sabraj Gill & Manish K. Aghi. (2022) Resistance to immune checkpoint blockade: Mechanisms, counter-acting approaches, and future directions. Seminars in Cancer Biology 86, pages 532-541.
Crossref
Crossref
Zhi Li, Zewen K. Tuong, Isaac Dean, Claire Willis, Fabrina Gaspal, Rémi Fiancette, Suaad Idris, Bethany Kennedy, John R. Ferdinand, Ana Peñalver, Mia Cabantous, Syed Murtuza Baker, Jeremy W. Fry, Gianluca Carlesso, Scott A. Hammond, Simon J. Dovedi, Matthew R. Hepworth, Menna R. Clatworthy & David R. Withers. (2022) In vivo labeling reveals continuous trafficking of TCF-1+ T cells between tumor and lymphoid tissue. Journal of Experimental Medicine 219:6.
Crossref
Crossref
Lauren Dennison, Amanda Ruggieri, Aditya Mohan, James Leatherman, Kayla Cruz, Skylar Woolman, Nilofer Azad, Gregory B. Lesinski, Elizabeth M. Jaffee & Mark Yarchoan. (2021) Context-Dependent Immunomodulatory Effects of MEK Inhibition Are Enhanced with T-cell Agonist Therapy. Cancer Immunology Research 9:10, pages 1187-1201.
Crossref
Crossref
Roberta Kiffin, Junko Johansson, Roger Olofsson Bagge & Anna Martner. (2021) Anti-PD-1 checkpoint blockade improves the efficacy of a melphalan-based therapy in experimental melanoma. European Journal of Surgical Oncology 47:9, pages 2460-2464.
Crossref
Crossref
Claudia Cocco, Fabio Morandi & Irma Airoldi. (2021) Immune Checkpoints in Pediatric Solid Tumors: Targetable Pathways for Advanced Therapeutic Purposes. Cells 10:4, pages 927.
Crossref
Crossref
Ahmed I. Younes, Hampartsoum B. Barsoumian, Duygu Sezen, Vivek Verma, Roshal Patel, Mark Wasley, Yun Hu, Joe D. Dunn, Kewen He, Dawei Chen, Hari Menon, Fatemeh Masrorpour, Meidi Gu, Liangpeng Yang, Nahum Puebla-Osorio, Maria Angelica Cortez & James W. Welsh. (2021) Addition of TLR9 agonist immunotherapy to radiation improves systemic antitumor activity. Translational Oncology 14:2, pages 100983.
Crossref
Crossref
Lisa K. Puntigam, Sandra S. Jeske, Marlies Götz, Jochen Greiner, Simon Laban, Marie-Nicole Theodoraki, Johannes Doescher, Stephanie E. Weissinger, Cornelia Brunner, Thomas K. Hoffmann & Patrick J. Schuler. (2020) Immune Checkpoint Expression on Immune Cells of HNSCC Patients and Modulation by Chemo- and Immunotherapy. International Journal of Molecular Sciences 21:15, pages 5181.
Crossref
Crossref
Meng Zhang, Yanmei Shi, Yujuan Zhang, Yifan Wang, Faizah Alotaibi, Li Qiu, Hongmei Wang, Shanshan Peng, Yanling Liu, Qing Li, Dian Gao, Zhigang Wang, Keng Yuan, Fang-fang Dou, James Koropatnick, Jianping Xiong & Weiping Min. (2020) miRNA-5119 regulates immune checkpoints in dendritic cells to enhance breast cancer immunotherapy. Cancer Immunology, Immunotherapy 69:6, pages 951-967.
Crossref
Crossref
Heriberto Prado-Garcia & Susana Romero-Garcia. 2020. Cancer Immunology. Cancer Immunology
117
132
.
Anne Monette, Derek Bergeron, Amira Ben Amor, Liliane Meunier, Christine Caron, Anne-Marie Mes-Masson, Nidhameddine Kchir, Kamel Hamzaoui, Igor Jurisica & Réjean Lapointe. (2019) Immune-enrichment of non-small cell lung cancer baseline biopsies for multiplex profiling define prognostic immune checkpoint combinations for patient stratification. Journal for ImmunoTherapy of Cancer 7:1.
Crossref
Crossref
Chao Chen, Xiang Ni, Shaorui Jia, Yong Liang, Xiaoli Wu, Deling Kong & Dan Ding. (2019) Massively Evoking Immunogenic Cell Death by Focused Mitochondrial Oxidative Stress using an AIE Luminogen with a Twisted Molecular Structure. Advanced Materials 31:52, pages 1904914.
Crossref
Crossref
Meng Zhang, Dian Gao, Yanmei Shi, Yifan Wang, Rakesh Joshi, Qiongfang Yu, Daheng Liu, Faizah Alotaibi, Yujuan Zhang, Hongmei Wang, Qing Li, Zhu-Xu Zhang, James Koropatnick & Weiping Min. (2019)
miR-149-3p reverses CD8
+
T-cell exhaustion by reducing inhibitory receptors and promoting cytokine secretion in breast cancer cells
. Open Biology 9:10, pages 190061.
Crossref
Crossref
Wang, Wu & Ma. (2019) Integrative Analysis of Cancer Omics Data for Prognosis Modeling. Genes 10:8, pages 604.
Crossref
Crossref
Annika De Sousa Linhares, Claire Battin, Sabrina Jutz, Judith Leitner, Christine Hafner, Joshua Tobias, Ursula Wiedermann, Michael Kundi, Gerhard J. Zlabinger, Katharina Grabmeier-Pfistershammer & Peter Steinberger. (2019) Therapeutic PD-L1 antibodies are more effective than PD-1 antibodies in blocking PD-1/PD-L1 signaling. Scientific Reports 9:1.
Crossref
Crossref
Ru Zhou, Mahboubeh Yazdanifar, Lopamudra Das Roy, Lynsey M. Whilding, Artemis Gavrill, John Maher & Pinku Mukherjee. (2019) CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth. Frontiers in Immunology 10.
Crossref
Crossref
Andrea Ladányi, Bence Kapuvári, Eszter Papp, Erika Tóth, József Lövey, Katalin Horváth, Mária Gődény & Éva Remenár. (2018) Local immune parameters as potential predictive markers in head and neck squamous cell carcinoma patients receiving induction chemotherapy and cetuximab. Head & Neck 41:5, pages 1237-1245.
Crossref
Crossref
Christopher D. Zahm, Viswa T. Colluru, Sean J. McIlwain, Irene M. Ong & Douglas G. McNeel. (2018) TLR Stimulation during T-cell Activation Lowers PD-1 Expression on CD8+ T Cells. Cancer Immunology Research 6:11, pages 1364-1374.
Crossref
Crossref
Manfred Kunz, Henry Löffler-Wirth, Michael Dannemann, Edith Willscher, Gero Doose, Janet Kelso, Tina Kottek, Birgit Nickel, Lydia Hopp, Jenny Landsberg, Steve Hoffmann, Thomas Tüting, Paola Zigrino, Cornelia Mauch, Jochen Utikal, Mirjana Ziemer, Hans-Joachim Schulze, Michael Hölzel, Alexander Roesch, Susanne Kneitz, Svenja Meierjohann, Anja Bosserhoff, Hans Binder & Manfred Schartl. (2018) RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomas. Oncogene 37:47, pages 6136-6151.
Crossref
Crossref
Annika De Sousa Linhares, Judith Leitner, Katharina Grabmeier-Pfistershammer & Peter Steinberger. (2018) Not All Immune Checkpoints Are Created Equal. Frontiers in Immunology 9.
Crossref
Crossref
Wenjun Wang, Xiaojun Xia, Sipei Wu, Minzhang Guo, Puyi Lie & Jianxing He. (2017) Cancer immunotherapy: A need for peripheral immunodynamic monitoring. American Journal of Reproductive Immunology 79:6.
Crossref
Crossref
Cassian Yee. (2018) Adoptive T cell therapy: points to consider. Current Opinion in Immunology 51, pages 197-203.
Crossref
Crossref
Ryo Arai, Sayo Soda, Tomoko Okutomi, Hiroko Morita, Fumito Ohmi, Tomoe Funakoshi, Akihiro Takemasa & Yoshiki Ishii. (2018) Lipid Accumulation in Peripheral Blood Dendritic Cells and Anticancer Immunity in Patients with Lung Cancer. Journal of Immunology Research 2018, pages 1-8.
Crossref
Crossref
Joshua ChanPatrick Y. KimEmiko KranzYoshiko NagaokaYooJin LeeJing WenHeidi J. ElsaesserMeng QinDavid G. BrooksGene-Errol RingpisIrvin S.Y. ChenMasakazu Kamata. (2017) Purging Exhausted Virus-Specific CD8 T Cell Phenotypes by Somatic Cell Reprogramming. AIDS Research and Human Retroviruses 33:S1, pages S-59-S-69.
Crossref
Crossref
Isobel S. Okoye, Michael Houghton, Lorne Tyrrell, Khaled Barakat & Shokrollah Elahi. (2017) Coinhibitory Receptor Expression and Immune Checkpoint Blockade: Maintaining a Balance in CD8+ T Cell Responses to Chronic Viral Infections and Cancer. Frontiers in Immunology 8.
Crossref
Crossref
Heriberto Prado-Garcia, Susana Romero-Garcia, Alejandra Puerto-Aquino & Uriel Rumbo-Nava. (2017) The PD-L1/PD-1 pathway promotes dysfunction, but not “exhaustion”, in tumor-responding T cells from pleural effusions in lung cancer patients. Cancer Immunology, Immunotherapy 66:6, pages 765-776.
Crossref
Crossref
Elizabeth C. Nowak, J. Louise Lines, Frederick S. Varn, Jie Deng, Aurelien Sarde, Rodwell Mabaera, Anna Kuta, Isabelle Le Mercier, Chao Cheng & Randolph J. Noelle. (2017) Immunoregulatory functions of VISTA. Immunological Reviews 276:1, pages 66-79.
Crossref
Crossref
Martin Rao, Davide Valentini, Ernest Dodoo, Alimuddin Zumla & Markus Maeurer. (2017) Anti-PD-1/PD-L1 therapy for infectious diseases: learning from the cancer paradigm. International Journal of Infectious Diseases 56, pages 221-228.
Crossref
Crossref
César Muñoz-Fontela, Anna Mandinova, Stuart A. Aaronson & Sam W. Lee. (2016) Emerging roles of p53 and other tumour-suppressor genes in immune regulation. Nature Reviews Immunology 16:12, pages 741-750.
Crossref
Crossref
Lili Wang, Yongxiang Yi, Dandan Yin, Zhenxian Zhou, Jing Fan, Wei Ye & Wei Zhao. (2016) Augmented CD3+CD8+ and CD3+CD56− cells in cytokine-induced killer cells cultured with engineered cells for costimulatory enhancement from heavily pretreated patients with solid tumor. Cytotherapy 18:4, pages 581-589.
Crossref
Crossref
Shu Chen, Guoying Ni, Xiaolian Wu, Bin Zhu, Zaowen Liao, Yuejian Wang & Xiaosong Liu. (2016) Blocking IL-10 signalling at the time of immunization renders the tumour more accessible to T cell infiltration in mice. Cellular Immunology 300, pages 9-17.
Crossref
Crossref
Laszlo G. Radvanyi. (2015) Tumor-Infiltrating Lymphocyte Therapy. The Cancer Journal 21:6, pages 450-464.
Crossref
Crossref
Chao FengLi-Juan CaoHua-Feng SongPing XuHui ChenJun-Chi XuXiao-Yan ZhuXue-Guang ZhangXue-Feng Wang. (2015) Expression of PD-L1 on CD4+CD25+Foxp3+ Regulatory T Cells of Patients with Chronic HBV Infection and Its Correlation with Clinical Parameters. Viral Immunology 28:8, pages 418-424.
Crossref
Crossref
Andrea Ladányi. (2015) Prognostic and predictive significance of immune cells infiltrating cutaneous melanoma. Pigment Cell & Melanoma Research 28:5, pages 490-500.
Crossref
Crossref
Barun Mahata, Soumika Biswas, Patricia Rayman, Ali Chahlavi, Jennifer Ko, Ashish Bhattacharjee, Yu-Teh Li, Yuntao Li, Tanya Das, Gaurisankar Sa, Baisakhi Raychaudhuri, Michael A. Vogelbaum, Charles Tannenbaum, James H. Finke & Kaushik Biswas. (2015) GBM Derived Gangliosides Induce T Cell Apoptosis through Activation of the Caspase Cascade Involving Both the Extrinsic and the Intrinsic Pathway. PLOS ONE 10:7, pages e0134425.
Crossref
Crossref
Jin-Young Choi, John Hsi-en Ho, Sandra G. Pasoto, Viviane Bunin, Sang Taek Kim, Solange Carrasco, Eduardo F. Borba, Celio R. Gonçalves, Priscila R. Costa, Esper G. Kallas, Eloisa Bonfa & Joseph Craft. (2015) Circulating Follicular Helper-Like T Cells in Systemic Lupus Erythematosus: Association With Disease Activity. Arthritis & Rheumatology 67:4, pages 988-999.
Crossref
Crossref
Stefanie N. Linch, Michael J. McNamara & William L. Redmond. (2015) OX40 Agonists and Combination Immunotherapy: Putting the Pedal to the Metal. Frontiers in Oncology 5.
Crossref
Crossref
Heriberto Prado-Garcia, Susana Romero-Garcia & Jose Sullivan Lopez-Gonzalez. 2015. Cancer Immunology. Cancer Immunology
61
75
.
Joel Crespo, Ilona Kryczek, Theodore Welling, Shuang Wei & Weiping Zou. 2015. Developments in T Cell Based Cancer Immunotherapies. Developments in T Cell Based Cancer Immunotherapies
53
74
.
Wieger J. Norde, Willemijn Hobo & Harry Dolstra. 2015. Resistance of Cancer Cells to CTL-Mediated Immunotherapy. Resistance of Cancer Cells to CTL-Mediated Immunotherapy
31
58
.
Lingfei Han, Wei Wang, Jiahong Lu, Fanfei Kong, Ge Ma, Yiping Zhu, Dong Zhao, Jianlong Zhu, Wen Shuai, Qian Zhou, Ping Chen, Lei Ye, Jie Tao, Sarfraz Ahmad, Fang Li & Jing Sun. (2014) AAV–sBTLA facilitates HSP70 vaccine-triggered prophylactic antitumor immunity against a murine melanoma pulmonary metastasis model in vivo. Cancer Letters 354:2, pages 398-406.
Crossref
Crossref
Miles C Andrews, Katherine Woods, Jonathan Cebon & Andreas Behren. (2014) Evolving role of tumor antigens for future melanoma therapies. Future Oncology 10:8, pages 1457-1468.
Crossref
Crossref
Ping Xu, Yong-Jing Chen, Hui Chen, Xiao-Yan Zhu, Hua-Feng Song, Li-Juan Cao & Xue-Feng Wang. (2014)
The Expression of Programmed Death-1 in Circulating CD4
+
and CD8
+
T Cells during Hepatitis B Virus Infection Progression and Its Correlation with Clinical Baseline Characteristics
. Gut and Liver 8:2, pages 186-195.
Crossref
Crossref
Jingting Jiang, Changping Wu & Binfeng Lu. (2013) Cytokine-induced killer cells promote antitumor immunity. Journal of Translational Medicine 11:1.
Crossref
Crossref
Joel Crespo, Haoyu Sun, Theodore H Welling, Zhigang Tian & Weiping Zou. (2013) T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment. Current Opinion in Immunology 25:2, pages 214-221.
Crossref
Crossref
M. J. P. Welters & S. H. van der Burg. 2013. The Tumor Immunoenvironment. The Tumor Immunoenvironment
107
133
.